Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

TUMOUR NECROSIS FACTOR ALPHA INHIBITOR TREATMENT NORMALISES HAND ONE LOSS IN A MINORITY OF RHEUMATOID ARTHRITIS PATIENTS TREATED IN CLINICAL PRACTICE. RESULTS FROM THE COPENHAGEN OSTEOARTHRITIS STUDY AND THE DANBIO REGISTRY

Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume74
Issue numberSuppl. 2
Pages (from-to)677
Number of pages1
ISSN0003-4967
Publication statusPublished - 2015

Bibliographical note

COPECARE

ID: 45924810